NHS
Healthcare UK appoints medical director
November 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, healthcare uk
Professor Rory Shaw has been hired as the medical director of Healthcare UK to lead the newly-established NHS International Development …
Charge more for prescriptions in England, say Reform
November 19, 2013Sales and Marketing GP, NHS, UK, doctors, prescriptions, reform
Increase prescriptions to £10 and charge the same amount to see a GP if you want to help the NHS …
NICE tells pharma: don’t blame us for rejections
November 18, 2013Sales and Marketing Dillon, NHS, NICE, VBP
The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …
Is the NHS in safe hands?
November 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, McConaghie, NHS
A total of 16 months have passed since Jeremy Hunt took over as health secretary from Andrew Lansley, and in …
‘Old fashioned’ doctors in new GP contract
November 15, 2013Sales and Marketing BMA, GP, Hunt, Labour, NHS, UK, doctors
The government is changing GPs’ contract with the NHS in a bid to “bring back old-fashioned family doctors” who will …
NHS Confederation hires new chief executive and deputy chair
November 12, 2013Sales and Marketing Mike Farrar, NHS, NHS Confederation, Rob webster, cash
The NHS Confederation has confirmed that Rob Webster is to succeed Mike Farrar as its new chief executive, as it …
NICE needs more Velcade data
November 12, 2013Sales and Marketing NHS, NICE, Velcade, eric low
NICE has slowed the progress of Janssen Cilag’s Velcade towards becoming an NHS treatment for multiple myeloma by asking the …
PPRS: thumbs-down from pharma
November 7, 2013Sales and Marketing ABPI, NHS, PPRS, Pfizer, VBP
A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …
PPRS to remain in UK, but drug growth curbed
November 6, 2013Sales and Marketing ABPI, DH, Deepak Khanna, NHS, PPRS
The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …
NICE ‘yes’ for Jetrea
October 23, 2013Sales and Marketing Jetrea, NHS, NICE, eye
Jetrea has completed its seemingly inexorable journey to NHS use in England and Wales for a rare eye condition following …
Astellas gets NICE nod
October 18, 2013Sales and Marketing Cancer, NHS, NICE, Xtandi
Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …
Patients should ‘top up’ NHS costs
October 16, 2013Sales and Marketing Dixon, England, NHS, NICE, top up
A leading doctor believes that NHS patients must produce top up payments for treatments for non-life threatening conditions. Speaking at …
Trials and tribulations
October 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, eric low, myeloma, transparency
I have been chief executive of Myeloma UK since its inception 17 years ago, and its unique bedside to bench …
NHS ‘behind the curve’, warns government
October 10, 2013Medical Communications, Sales and Marketing NHS, curve, technology
The government is on track to deliver a paperless NHS by 2018, according to parliamentary undersecretary of state for health …
New UK drug pricing plans ‘delayed’
October 7, 2013Medical Communications, Sales and Marketing Drug pricing, Hunt, Lansley, NHS, NICE, VBP
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
